| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Women's Health | 59 | 2023 | 242 | 9.100 |
Why?
|
| Menopause | 35 | 2023 | 131 | 6.330 |
Why?
|
| Sleep | 28 | 2022 | 322 | 4.310 |
Why?
|
| Depression | 27 | 2022 | 481 | 3.030 |
Why?
|
| Sleep Wake Disorders | 13 | 2021 | 149 | 2.760 |
Why?
|
| Middle Aged | 106 | 2023 | 10240 | 2.170 |
Why?
|
| Female | 123 | 2023 | 17017 | 2.040 |
Why?
|
| Body Mass Index | 16 | 2022 | 453 | 2.000 |
Why?
|
| Longitudinal Studies | 43 | 2022 | 1507 | 1.900 |
Why?
|
| Metabolic Syndrome | 5 | 2020 | 68 | 1.860 |
Why?
|
| Perimenopause | 9 | 2022 | 23 | 1.670 |
Why?
|
| United States | 47 | 2021 | 2376 | 1.620 |
Why?
|
| Humans | 140 | 2023 | 31073 | 1.560 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 9 | 2020 | 61 | 1.550 |
Why?
|
| Depressive Disorder, Major | 9 | 2020 | 108 | 1.540 |
Why?
|
| Adult | 81 | 2023 | 8950 | 1.450 |
Why?
|
| Obesity | 4 | 2020 | 307 | 1.300 |
Why?
|
| Cardiovascular Diseases | 8 | 2022 | 428 | 1.190 |
Why?
|
| Sexuality | 2 | 2018 | 17 | 1.150 |
Why?
|
| Weight Gain | 3 | 2018 | 70 | 1.140 |
Why?
|
| Actigraphy | 10 | 2022 | 99 | 1.130 |
Why?
|
| Depressive Disorder | 18 | 2017 | 192 | 1.110 |
Why?
|
| Polysomnography | 23 | 2021 | 99 | 1.110 |
Why?
|
| Cohort Studies | 21 | 2021 | 2046 | 0.990 |
Why?
|
| Cross-Sectional Studies | 25 | 2022 | 1006 | 0.980 |
Why?
|
| Adiposity | 4 | 2020 | 45 | 0.930 |
Why?
|
| Sex Offenses | 4 | 2023 | 22 | 0.920 |
Why?
|
| Pelvic Floor Disorders | 1 | 2023 | 10 | 0.850 |
Why?
|
| Urinary Incontinence | 1 | 2023 | 24 | 0.840 |
Why?
|
| Complementary Therapies | 1 | 2022 | 10 | 0.840 |
Why?
|
| Energy Metabolism | 2 | 2018 | 54 | 0.750 |
Why?
|
| Cognition Disorders | 4 | 2020 | 1057 | 0.750 |
Why?
|
| Health Surveys | 11 | 2016 | 99 | 0.740 |
Why?
|
| Pharmacoepidemiology | 1 | 2020 | 5 | 0.730 |
Why?
|
| Socioeconomic Factors | 14 | 2020 | 334 | 0.720 |
Why?
|
| Multimorbidity | 1 | 2020 | 8 | 0.720 |
Why?
|
| Waist Circumference | 3 | 2016 | 36 | 0.720 |
Why?
|
| Fibromyalgia | 3 | 2015 | 31 | 0.710 |
Why?
|
| Risk Factors | 29 | 2022 | 2591 | 0.710 |
Why?
|
| Menopause, Premature | 1 | 2020 | 6 | 0.700 |
Why?
|
| Hysterectomy | 1 | 2020 | 21 | 0.700 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 30 | 0.670 |
Why?
|
| Financing, Organized | 1 | 2019 | 9 | 0.670 |
Why?
|
| Follow-Up Studies | 15 | 2020 | 1935 | 0.660 |
Why?
|
| Body Composition | 1 | 2019 | 67 | 0.650 |
Why?
|
| Sleep Apnea Syndromes | 5 | 2014 | 32 | 0.650 |
Why?
|
| Stair Climbing | 1 | 2019 | 4 | 0.650 |
Why?
|
| Employment | 2 | 2022 | 43 | 0.650 |
Why?
|
| Healthy Aging | 1 | 2019 | 16 | 0.640 |
Why?
|
| Appetite | 1 | 2018 | 5 | 0.640 |
Why?
|
| Gynecology | 1 | 2018 | 10 | 0.640 |
Why?
|
| Chronic Disease | 2 | 2020 | 534 | 0.630 |
Why?
|
| Quality of Life | 2 | 2022 | 696 | 0.630 |
Why?
|
| Pain | 3 | 2023 | 426 | 0.610 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2023 | 9 | 0.610 |
Why?
|
| Climacteric | 6 | 2009 | 10 | 0.600 |
Why?
|
| Self Report | 8 | 2020 | 231 | 0.600 |
Why?
|
| Affect | 4 | 2021 | 66 | 0.590 |
Why?
|
| Anxiety | 4 | 2015 | 156 | 0.570 |
Why?
|
| Beverages | 1 | 2016 | 10 | 0.560 |
Why?
|
| Waist-Height Ratio | 1 | 2016 | 6 | 0.560 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 14 | 0.550 |
Why?
|
| Aging | 7 | 2020 | 1729 | 0.550 |
Why?
|
| Chronic Pain | 2 | 2014 | 111 | 0.550 |
Why?
|
| Cognition | 6 | 2021 | 1428 | 0.540 |
Why?
|
| Premenopause | 9 | 2022 | 21 | 0.540 |
Why?
|
| Menstrual Cycle | 3 | 2017 | 31 | 0.530 |
Why?
|
| Social Class | 4 | 2017 | 69 | 0.520 |
Why?
|
| Dyspareunia | 1 | 2015 | 7 | 0.520 |
Why?
|
| Stress, Psychological | 10 | 2015 | 254 | 0.510 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2006 | 318 | 0.500 |
Why?
|
| Mass Screening | 1 | 2016 | 186 | 0.500 |
Why?
|
| Meals | 1 | 2014 | 12 | 0.490 |
Why?
|
| Prevalence | 10 | 2016 | 499 | 0.480 |
Why?
|
| Follicle Stimulating Hormone | 9 | 2023 | 22 | 0.480 |
Why?
|
| C-Reactive Protein | 5 | 2016 | 128 | 0.470 |
Why?
|
| Hot Flashes | 6 | 2020 | 16 | 0.460 |
Why?
|
| Personal Satisfaction | 1 | 2014 | 49 | 0.450 |
Why?
|
| Body Image | 1 | 2014 | 31 | 0.450 |
Why?
|
| Time Factors | 14 | 2020 | 1680 | 0.440 |
Why?
|
| Pain Measurement | 2 | 2015 | 489 | 0.440 |
Why?
|
| Prejudice | 5 | 2015 | 41 | 0.440 |
Why?
|
| Postoperative Complications | 1 | 2020 | 997 | 0.440 |
Why?
|
| Psychiatric Status Rating Scales | 11 | 2014 | 356 | 0.420 |
Why?
|
| Adult Survivors of Child Adverse Events | 3 | 2017 | 4 | 0.420 |
Why?
|
| Prospective Studies | 7 | 2020 | 1899 | 0.410 |
Why?
|
| Postmenopause | 7 | 2019 | 62 | 0.390 |
Why?
|
| Mood Disorders | 1 | 2011 | 32 | 0.390 |
Why?
|
| Electroencephalography | 5 | 2021 | 136 | 0.360 |
Why?
|
| Air Pollution | 2 | 2023 | 18 | 0.360 |
Why?
|
| Testosterone | 5 | 2011 | 32 | 0.350 |
Why?
|
| Alcoholism | 5 | 2000 | 85 | 0.350 |
Why?
|
| Estradiol | 6 | 2021 | 46 | 0.350 |
Why?
|
| Mental Disorders | 5 | 2002 | 145 | 0.350 |
Why?
|
| Surveys and Questionnaires | 11 | 2019 | 1209 | 0.350 |
Why?
|
| Hormones | 3 | 2017 | 11 | 0.340 |
Why?
|
| Premenstrual Syndrome | 3 | 2012 | 6 | 0.340 |
Why?
|
| Incidence | 4 | 2020 | 790 | 0.330 |
Why?
|
| Brain | 4 | 2015 | 1797 | 0.330 |
Why?
|
| Alprazolam | 5 | 1993 | 24 | 0.330 |
Why?
|
| Comorbidity | 6 | 2015 | 508 | 0.320 |
Why?
|
| Child Abuse | 3 | 2020 | 38 | 0.320 |
Why?
|
| Health Status | 5 | 2018 | 239 | 0.320 |
Why?
|
| Aged | 16 | 2022 | 10082 | 0.310 |
Why?
|
| Luteinizing Hormone | 3 | 2021 | 9 | 0.310 |
Why?
|
| Particulate Matter | 3 | 2023 | 24 | 0.300 |
Why?
|
| Age Factors | 6 | 2020 | 875 | 0.300 |
Why?
|
| Fibrinogen | 3 | 2016 | 20 | 0.290 |
Why?
|
| Feeding and Eating Disorders | 1 | 2007 | 12 | 0.290 |
Why?
|
| Crime | 3 | 2002 | 10 | 0.290 |
Why?
|
| Hypertension | 3 | 2014 | 288 | 0.290 |
Why?
|
| Odds Ratio | 5 | 2017 | 293 | 0.290 |
Why?
|
| Child | 7 | 2023 | 1431 | 0.280 |
Why?
|
| Prognosis | 4 | 2020 | 924 | 0.280 |
Why?
|
| Anxiety Disorders | 6 | 2012 | 171 | 0.270 |
Why?
|
| Residence Characteristics | 2 | 2007 | 225 | 0.270 |
Why?
|
| Hemostasis | 2 | 2016 | 11 | 0.270 |
Why?
|
| Recurrence | 7 | 2016 | 375 | 0.270 |
Why?
|
| Gonadal Hormones | 1 | 2005 | 3 | 0.260 |
Why?
|
| Paraphilic Disorders | 2 | 1996 | 2 | 0.260 |
Why?
|
| Medroxyprogesterone Acetate | 2 | 1996 | 5 | 0.260 |
Why?
|
| Chicago | 4 | 2019 | 941 | 0.250 |
Why?
|
| Prisoners | 2 | 2002 | 10 | 0.250 |
Why?
|
| Commitment of Mentally Ill | 2 | 2002 | 2 | 0.250 |
Why?
|
| Lipoproteins, HDL | 2 | 2014 | 30 | 0.240 |
Why?
|
| Logistic Models | 8 | 2014 | 411 | 0.240 |
Why?
|
| Patient Compliance | 5 | 1999 | 158 | 0.240 |
Why?
|
| Movement | 2 | 2015 | 137 | 0.230 |
Why?
|
| Suicide, Attempted | 2 | 1994 | 14 | 0.230 |
Why?
|
| Pregnanediol | 2 | 2021 | 6 | 0.230 |
Why?
|
| Vasomotor System | 3 | 2021 | 5 | 0.230 |
Why?
|
| Air Pollutants | 1 | 2023 | 13 | 0.220 |
Why?
|
| Hormone Replacement Therapy | 2 | 2022 | 32 | 0.220 |
Why?
|
| Lithium | 3 | 1999 | 22 | 0.220 |
Why?
|
| Bipolar Disorder | 5 | 1994 | 130 | 0.220 |
Why?
|
| Inflammation | 2 | 2016 | 361 | 0.220 |
Why?
|
| Heart Rate | 2 | 2014 | 160 | 0.220 |
Why?
|
| Pelvic Floor | 1 | 2023 | 11 | 0.220 |
Why?
|
| Male | 26 | 2019 | 16499 | 0.210 |
Why?
|
| Adaptation, Physiological | 2 | 2020 | 57 | 0.200 |
Why?
|
| Reference Values | 3 | 2013 | 230 | 0.200 |
Why?
|
| Prescriptions | 1 | 2021 | 18 | 0.190 |
Why?
|
| Progesterone | 1 | 2021 | 21 | 0.190 |
Why?
|
| Obesity, Abdominal | 2 | 2011 | 21 | 0.190 |
Why?
|
| Desipramine | 3 | 1990 | 6 | 0.190 |
Why?
|
| Insulin Resistance | 2 | 2016 | 60 | 0.190 |
Why?
|
| Intra-Abdominal Fat | 2 | 2011 | 44 | 0.180 |
Why?
|
| Adipose Tissue | 2 | 2019 | 78 | 0.180 |
Why?
|
| Personality | 2 | 2014 | 68 | 0.180 |
Why?
|
| Antidepressive Agents | 2 | 2000 | 100 | 0.180 |
Why?
|
| Ambulatory Care | 2 | 1999 | 79 | 0.180 |
Why?
|
| Work Schedule Tolerance | 1 | 2020 | 40 | 0.180 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2020 | 41 | 0.180 |
Why?
|
| Ovariectomy | 1 | 2020 | 27 | 0.180 |
Why?
|
| Insanity Defense | 1 | 1999 | 1 | 0.170 |
Why?
|
| Forensic Psychiatry | 1 | 1999 | 4 | 0.170 |
Why?
|
| Sleep Deprivation | 1 | 2020 | 65 | 0.170 |
Why?
|
| Electric Impedance | 1 | 2019 | 25 | 0.170 |
Why?
|
| Preoperative Period | 1 | 2020 | 76 | 0.170 |
Why?
|
| Life Style | 4 | 2015 | 226 | 0.170 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 88 | 0.170 |
Why?
|
| Factor VII | 2 | 2016 | 2 | 0.170 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2016 | 4 | 0.170 |
Why?
|
| Sleep Stages | 3 | 2013 | 34 | 0.170 |
Why?
|
| Analysis of Variance | 7 | 2013 | 326 | 0.160 |
Why?
|
| Michigan | 1 | 2019 | 14 | 0.160 |
Why?
|
| Blood Pressure | 3 | 2014 | 262 | 0.160 |
Why?
|
| Smoking | 3 | 2014 | 197 | 0.160 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 1134 | 0.160 |
Why?
|
| Health Behavior | 3 | 2014 | 163 | 0.160 |
Why?
|
| Adipokines | 1 | 2018 | 8 | 0.160 |
Why?
|
| Adiponectin | 1 | 2018 | 9 | 0.160 |
Why?
|
| Child Abuse, Sexual | 2 | 1996 | 11 | 0.160 |
Why?
|
| Postoperative Period | 1 | 2020 | 303 | 0.160 |
Why?
|
| Attention | 2 | 2020 | 145 | 0.150 |
Why?
|
| Snoring | 2 | 2016 | 5 | 0.150 |
Why?
|
| Women | 3 | 2004 | 15 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2019 | 144 | 0.150 |
Why?
|
| Multivariate Analysis | 5 | 2013 | 344 | 0.150 |
Why?
|
| Autonomic Nervous System | 2 | 2014 | 20 | 0.150 |
Why?
|
| Suicide | 2 | 1997 | 14 | 0.150 |
Why?
|
| Sweating | 2 | 2015 | 3 | 0.150 |
Why?
|
| Estrogens | 1 | 2017 | 36 | 0.150 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 147 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 148 | 0.140 |
Why?
|
| Biomarkers | 3 | 2016 | 734 | 0.140 |
Why?
|
| Aromatase | 2 | 2006 | 3 | 0.140 |
Why?
|
| Cytochrome P-450 CYP1B1 | 2 | 2006 | 3 | 0.140 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 2 | 2006 | 5 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2017 | 73 | 0.140 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2006 | 5 | 0.140 |
Why?
|
| Exercise | 3 | 2022 | 505 | 0.140 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2006 | 9 | 0.140 |
Why?
|
| Alcohol Drinking | 2 | 2014 | 79 | 0.140 |
Why?
|
| Support Vector Machine | 1 | 2016 | 6 | 0.140 |
Why?
|
| Proof of Concept Study | 1 | 2016 | 14 | 0.140 |
Why?
|
| Energy Intake | 1 | 2016 | 73 | 0.140 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2016 | 20 | 0.140 |
Why?
|
| Ozone | 1 | 2016 | 1 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 2016 | 17 | 0.130 |
Why?
|
| Causality | 1 | 2015 | 54 | 0.130 |
Why?
|
| Sexual Behavior | 4 | 2004 | 61 | 0.130 |
Why?
|
| Blood Glucose | 2 | 2014 | 120 | 0.130 |
Why?
|
| Phenylalanine | 2 | 1986 | 6 | 0.130 |
Why?
|
| Global Health | 1 | 2015 | 58 | 0.130 |
Why?
|
| Allostasis | 1 | 2015 | 5 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 555 | 0.130 |
Why?
|
| Absorptiometry, Photon | 2 | 2012 | 83 | 0.130 |
Why?
|
| Hostility | 1 | 2015 | 22 | 0.130 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 1317 | 0.120 |
Why?
|
| Pennsylvania | 5 | 2016 | 15 | 0.120 |
Why?
|
| Disease Progression | 1 | 2018 | 833 | 0.120 |
Why?
|
| Hygiene | 1 | 2014 | 13 | 0.120 |
Why?
|
| Triglycerides | 1 | 2014 | 47 | 0.120 |
Why?
|
| Fear | 3 | 2013 | 47 | 0.120 |
Why?
|
| Valproic Acid | 1 | 1994 | 30 | 0.120 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 21 | 0.120 |
Why?
|
| Delta Rhythm | 2 | 2011 | 5 | 0.120 |
Why?
|
| Adolescent | 9 | 2012 | 2403 | 0.120 |
Why?
|
| Memory | 2 | 2015 | 330 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2009 | 214 | 0.120 |
Why?
|
| Dextroamphetamine | 2 | 1991 | 5 | 0.120 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 56 | 0.120 |
Why?
|
| Police | 1 | 1994 | 4 | 0.120 |
Why?
|
| Osteoarthritis | 1 | 2019 | 384 | 0.120 |
Why?
|
| Marriage | 1 | 1994 | 6 | 0.120 |
Why?
|
| Occupational Diseases | 1 | 1994 | 19 | 0.110 |
Why?
|
| Job Satisfaction | 1 | 1994 | 29 | 0.110 |
Why?
|
| Emigrants and Immigrants | 1 | 2014 | 20 | 0.110 |
Why?
|
| Pindolol | 1 | 1993 | 1 | 0.110 |
Why?
|
| Propranolol | 1 | 1993 | 10 | 0.110 |
Why?
|
| Acculturation | 1 | 2014 | 40 | 0.110 |
Why?
|
| Social Perception | 1 | 2013 | 23 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 86 | 0.110 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 44 | 0.110 |
Why?
|
| Sports | 1 | 2013 | 47 | 0.110 |
Why?
|
| Aortic Diseases | 1 | 2013 | 7 | 0.110 |
Why?
|
| Cross-Cultural Comparison | 3 | 2008 | 41 | 0.110 |
Why?
|
| Social Support | 2 | 2012 | 194 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2021 | 3665 | 0.110 |
Why?
|
| Menstruation Disturbances | 1 | 2012 | 2 | 0.110 |
Why?
|
| Imipramine | 1 | 1992 | 12 | 0.110 |
Why?
|
| Body Fat Distribution | 1 | 2012 | 12 | 0.110 |
Why?
|
| Marital Status | 2 | 2010 | 14 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 85 | 0.100 |
Why?
|
| Cultural Diversity | 2 | 2004 | 27 | 0.100 |
Why?
|
| Calcinosis | 1 | 2013 | 50 | 0.100 |
Why?
|
| Self Concept | 1 | 2012 | 44 | 0.100 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2013 | 66 | 0.100 |
Why?
|
| Overweight | 1 | 2013 | 69 | 0.100 |
Why?
|
| Muscle Spasticity | 1 | 1992 | 13 | 0.100 |
Why?
|
| Baclofen | 1 | 1992 | 14 | 0.100 |
Why?
|
| Beta Rhythm | 1 | 2011 | 5 | 0.100 |
Why?
|
| Emotions | 2 | 2009 | 89 | 0.100 |
Why?
|
| Spinal Cord Injuries | 1 | 1992 | 48 | 0.100 |
Why?
|
| Anti-Anxiety Agents | 2 | 2000 | 40 | 0.100 |
Why?
|
| Double-Blind Method | 5 | 2000 | 499 | 0.090 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 139 | 0.090 |
Why?
|
| Regression Analysis | 5 | 2016 | 301 | 0.090 |
Why?
|
| Menstruation | 2 | 2015 | 4 | 0.090 |
Why?
|
| Blood Coagulation Factors | 1 | 2010 | 19 | 0.090 |
Why?
|
| Phenylacetates | 2 | 1990 | 6 | 0.090 |
Why?
|
| Patient Education as Topic | 3 | 2009 | 161 | 0.090 |
Why?
|
| Buspirone | 2 | 2000 | 6 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 375 | 0.090 |
Why?
|
| Nocturnal Myoclonus Syndrome | 1 | 2009 | 7 | 0.080 |
Why?
|
| Self Care | 1 | 2009 | 91 | 0.080 |
Why?
|
| Benzodiazepines | 2 | 1993 | 58 | 0.080 |
Why?
|
| Illinois | 3 | 2004 | 267 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2000 | 143 | 0.070 |
Why?
|
| Food Preferences | 1 | 2007 | 22 | 0.070 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 42 | 0.070 |
Why?
|
| Educational Status | 5 | 2015 | 312 | 0.070 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2006 | 2 | 0.070 |
Why?
|
| Estrogen Receptor beta | 1 | 2006 | 4 | 0.070 |
Why?
|
| Estrogen Receptor alpha | 1 | 2006 | 15 | 0.070 |
Why?
|
| Phenethylamines | 1 | 1986 | 4 | 0.070 |
Why?
|
| Pedophilia | 2 | 1996 | 2 | 0.070 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2005 | 7 | 0.070 |
Why?
|
| Clergy | 2 | 1996 | 90 | 0.060 |
Why?
|
| Attitude to Health | 2 | 2008 | 99 | 0.060 |
Why?
|
| Personality Tests | 2 | 1999 | 9 | 0.060 |
Why?
|
| Mental Health | 3 | 2016 | 113 | 0.060 |
Why?
|
| Carbamazepine | 1 | 1985 | 13 | 0.060 |
Why?
|
| Genotype | 1 | 2006 | 428 | 0.060 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1985 | 22 | 0.060 |
Why?
|
| Sexual Partners | 1 | 2004 | 9 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2006 | 178 | 0.060 |
Why?
|
| Amino Acids | 1 | 1984 | 22 | 0.060 |
Why?
|
| Posture | 1 | 1985 | 72 | 0.060 |
Why?
|
| Clinical Trials as Topic | 4 | 1993 | 331 | 0.060 |
Why?
|
| Diet | 1 | 1986 | 194 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2023 | 1 | 0.060 |
Why?
|
| Japan | 3 | 2014 | 11 | 0.060 |
Why?
|
| Acute Disease | 1 | 2004 | 232 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2004 | 78 | 0.060 |
Why?
|
| China | 3 | 2014 | 57 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2014 | 225 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 370 | 0.050 |
Why?
|
| Monitoring, Ambulatory | 2 | 2014 | 20 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 59 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2002 | 41 | 0.050 |
Why?
|
| Receptors, Adrenergic | 1 | 1981 | 1 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1981 | 3 | 0.050 |
Why?
|
| Yohimbine | 1 | 1981 | 9 | 0.050 |
Why?
|
| Sleep, REM | 2 | 2011 | 18 | 0.050 |
Why?
|
| Asian Americans | 1 | 2001 | 1 | 0.050 |
Why?
|
| African Americans | 1 | 2001 | 1 | 0.050 |
Why?
|
| Substance-Related Disorders | 4 | 2008 | 93 | 0.050 |
Why?
|
| Blood Platelets | 1 | 1981 | 51 | 0.050 |
Why?
|
| Monocytes | 1 | 2002 | 115 | 0.050 |
Why?
|
| Linear Models | 2 | 2013 | 273 | 0.050 |
Why?
|
| Macrophages | 1 | 2002 | 137 | 0.050 |
Why?
|
| Energy Drinks | 1 | 2020 | 6 | 0.050 |
Why?
|
| Patient Readmission | 2 | 1999 | 132 | 0.050 |
Why?
|
| Apoptosis | 1 | 2002 | 260 | 0.050 |
Why?
|
| Waist-Hip Ratio | 1 | 2020 | 15 | 0.050 |
Why?
|
| Lithium Chloride | 1 | 2000 | 3 | 0.040 |
Why?
|
| Antimanic Agents | 1 | 2000 | 10 | 0.040 |
Why?
|
| Caffeine | 1 | 2020 | 66 | 0.040 |
Why?
|
| Fatigue | 1 | 2020 | 65 | 0.040 |
Why?
|
| Reaction Time | 1 | 2020 | 128 | 0.040 |
Why?
|
| Wakefulness | 2 | 2012 | 81 | 0.040 |
Why?
|
| Cytokines | 1 | 2002 | 351 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 51 | 0.040 |
Why?
|
| Interview, Psychological | 2 | 2011 | 36 | 0.040 |
Why?
|
| Remission Induction | 1 | 2000 | 105 | 0.040 |
Why?
|
| Melatonin | 1 | 2020 | 98 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2000 | 208 | 0.040 |
Why?
|
| Drug Therapy, Combination | 3 | 1991 | 246 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 294 | 0.040 |
Why?
|
| Leptin | 1 | 2018 | 24 | 0.040 |
Why?
|
| Psychological Tests | 1 | 2018 | 50 | 0.040 |
Why?
|
| Tritium | 2 | 1992 | 14 | 0.040 |
Why?
|
| Hospitalization | 2 | 1995 | 336 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2000 | 428 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 1999 | 3810 | 0.040 |
Why?
|
| Menarche | 1 | 2017 | 4 | 0.040 |
Why?
|
| Parity | 1 | 2017 | 4 | 0.040 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2017 | 4 | 0.040 |
Why?
|
| Models, Neurological | 1 | 1997 | 29 | 0.040 |
Why?
|
| Estrone | 1 | 2017 | 6 | 0.040 |
Why?
|
| Corpus Luteum | 1 | 2017 | 4 | 0.040 |
Why?
|
| Panic | 2 | 1990 | 13 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2013 | 818 | 0.040 |
Why?
|
| Serotonin | 2 | 1997 | 37 | 0.040 |
Why?
|
| Lactation | 1 | 2017 | 63 | 0.040 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2016 | 10 | 0.030 |
Why?
|
| Religion and Psychology | 1 | 1996 | 25 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 404 | 0.030 |
Why?
|
| Antigens | 1 | 2016 | 27 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1996 | 8 | 0.030 |
Why?
|
| Pedigree | 1 | 1996 | 75 | 0.030 |
Why?
|
| Family Health | 1 | 1996 | 37 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2016 | 43 | 0.030 |
Why?
|
| Survival Analysis | 1 | 1996 | 322 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2015 | 21 | 0.030 |
Why?
|
| Imagination | 1 | 1995 | 3 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 1995 | 12 | 0.030 |
Why?
|
| Self Disclosure | 1 | 1995 | 6 | 0.030 |
Why?
|
| Criminal Law | 1 | 1995 | 3 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 1995 | 47 | 0.030 |
Why?
|
| Schizophrenia | 1 | 1995 | 80 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 190 | 0.030 |
Why?
|
| Employee Discipline | 1 | 1994 | 1 | 0.030 |
Why?
|
| Work Capacity Evaluation | 1 | 1994 | 8 | 0.030 |
Why?
|
| Papanicolaou Test | 1 | 2013 | 9 | 0.030 |
Why?
|
| Vaginal Smears | 1 | 2013 | 15 | 0.030 |
Why?
|
| Personality Assessment | 1 | 1994 | 41 | 0.030 |
Why?
|
| Respiratory Rate | 1 | 2013 | 5 | 0.030 |
Why?
|
| Mammography | 1 | 2013 | 43 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 1993 | 76 | 0.030 |
Why?
|
| Irritable Mood | 1 | 2013 | 6 | 0.030 |
Why?
|
| Language | 1 | 2014 | 79 | 0.030 |
Why?
|
| Panic Disorder | 1 | 1993 | 131 | 0.030 |
Why?
|
| Psychometrics | 2 | 2009 | 270 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 89 | 0.030 |
Why?
|
| Menorrhagia | 1 | 2012 | 4 | 0.030 |
Why?
|
| Personality Inventory | 2 | 2007 | 75 | 0.030 |
Why?
|
| Exercise Test | 1 | 1993 | 129 | 0.030 |
Why?
|
| Infusion Pumps | 1 | 1992 | 17 | 0.030 |
Why?
|
| Health Promotion | 1 | 2014 | 164 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 149 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 1992 | 53 | 0.020 |
Why?
|
| Home Care Services | 1 | 2012 | 21 | 0.020 |
Why?
|
| Divorce | 1 | 1991 | 4 | 0.020 |
Why?
|
| Electromyography | 1 | 1992 | 78 | 0.020 |
Why?
|
| Pemoline | 1 | 1991 | 2 | 0.020 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1991 | 20 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2011 | 15 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 820 | 0.020 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2010 | 5 | 0.020 |
Why?
|
| Social Behavior | 1 | 2010 | 103 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2009 | 9 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 42 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2006 | 79 | 0.020 |
Why?
|
| MMPI | 2 | 1996 | 8 | 0.020 |
Why?
|
| Social Desirability | 2 | 1996 | 3 | 0.020 |
Why?
|
| Leukopenia | 1 | 1985 | 9 | 0.020 |
Why?
|
| Masturbation | 1 | 2004 | 2 | 0.020 |
Why?
|
| New Jersey | 1 | 2004 | 4 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 5197 | 0.010 |
Why?
|
| Oxygen | 1 | 1985 | 87 | 0.010 |
Why?
|
| Body Weight | 1 | 1985 | 141 | 0.010 |
Why?
|
| Data Collection | 1 | 2004 | 109 | 0.010 |
Why?
|
| Anemia | 1 | 1985 | 100 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2004 | 123 | 0.010 |
Why?
|
| Income | 1 | 2003 | 79 | 0.010 |
Why?
|
| Phobic Disorders | 1 | 1983 | 66 | 0.010 |
Why?
|
| Chemistry | 1 | 1982 | 2 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1982 | 4 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1982 | 11 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1982 | 54 | 0.010 |
Why?
|
| Anemia, Refractory, with Excess of Blasts | 1 | 2002 | 1 | 0.010 |
Why?
|
| Anemia, Refractory | 1 | 2002 | 2 | 0.010 |
Why?
|
| S Phase | 1 | 2002 | 10 | 0.010 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2002 | 4 | 0.010 |
Why?
|
| Kinetics | 1 | 1982 | 228 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 113 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2005 | 551 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1981 | 106 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 124 | 0.010 |
Why?
|
| Minority Groups | 1 | 2001 | 74 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 234 | 0.010 |
Why?
|
| Socioenvironmental Therapy | 1 | 2000 | 2 | 0.010 |
Why?
|
| Temperance | 1 | 2000 | 2 | 0.010 |
Why?
|
| Risk-Taking | 1 | 2000 | 33 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 1 | 1997 | 12 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1997 | 13 | 0.010 |
Why?
|
| Cholesterol | 1 | 1997 | 55 | 0.010 |
Why?
|
| Gender Identity | 1 | 1996 | 24 | 0.010 |
Why?
|
| Incest | 1 | 1996 | 1 | 0.010 |
Why?
|
| Catholicism | 1 | 1996 | 21 | 0.010 |
Why?
|
| Socialization | 1 | 1996 | 11 | 0.010 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 1995 | 5 | 0.010 |
Why?
|
| Hospitals, State | 1 | 1995 | 3 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 1995 | 24 | 0.010 |
Why?
|
| Probability | 1 | 1995 | 99 | 0.010 |
Why?
|
| Infant | 1 | 1996 | 577 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1996 | 691 | 0.010 |
Why?
|
| Sex Factors | 1 | 1995 | 510 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 4720 | 0.010 |
Why?
|
| Family Characteristics | 1 | 1991 | 19 | 0.010 |
Why?
|
| Life Change Events | 1 | 1991 | 38 | 0.010 |
Why?
|
| Social Adjustment | 1 | 1991 | 31 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1991 | 66 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1991 | 409 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1991 | 444 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1987 | 68 | 0.000 |
Why?
|